Polymer-Based Versus Polymer-Free Stents in High Bleeding Risk Patients
Stephan Windecker, Azeem Latib, Elvin Kedhi, Ajay J. Kirtane, David E. Kandzari, Roxana Mehran, Matthew J. Price, Alexandre Abizaid, Daniel I. Simon, Stephen G. Worthley, Azfar Zaman, Martin Hudec, Petra Poliačiková, Abdul Kahar bin Abdul Ghapar, Kamaraj Selvaraj, Ivo Petrov, Darren Mylotte, Eduardo Pinar, Raúl Moreno, Franco Fabbiocchi, Sanjeevan Pasupati, Hyo-Soo Kim, Adel Aminian, Charles Tie, Adrian Włodarczak, Seung-Ho Hur, Steven O. Marx, Ziad A. Ali, Maria Parke, Te‐Hsin Lung, Gregg W. Stone
Topics & Concepts
MedicineClinical endpointRandomized controlled trialZotarolimusAspirinSurgeryMyocardial infarctionStentIntention-to-treat analysisDiscontinuationClopidogrelInternal medicineDrug-eluting stentPercutaneous coronary interventionCoronary Interventions and DiagnosticsAntiplatelet Therapy and Cardiovascular DiseasesPeripheral Artery Disease Management